Minimize Uncertainty – Make Informed Decisions – Succeed

Respiratory

Respiratory Video Recap—February 20, 2026

February 20, 2026Respiratory syncytial virus infection,Kymera Therapeutics,cystic fibrosis,Devonian,astrazeneca,Thykamine,sanofi,KT-621,Beyfortus,Eradivir,Asthma,EV148,BioPharma and Tech News,Breztri,pulmonary hypertension,BI 3720931,pulmonary fibrosis,Bosentan,Boehringer Ingelheim,Pulmovant,Mosliciguat,pulmonary arterial hypertensionRespiratory News,zydus lifesciences

This biweekly Respiratory Video Recap summarizes key developments including…

by LucidQuest

Respiratory

Respiratory Today—February 20, 2026

February 20, 2026cystic fibrosis,astrazeneca,gsk,sanofi,RSV,BioPharma and Tech News,Idiopathic Pulmonary Fibrosis,pulmonary arterial hypertension,Respiratory News,respiratory syncytial virussevere asthma,interstitial lung disease

This week's Respiratory update  summarizes key developments in regulatory…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Altesa BioSciences $75 million Series B for vapendavir in COPD

February 20, 2026Respiratory,venture capital,clinical trials,market access,COPD,biopharma,diagnostics,licensing,Lucid Diligence Brief,diligence,antivirals,Series Bpayer evidence

Lucid Diligence Brief: Altesa BioSciences $75 million Series B for vapendavir…

by Timos Papagatsias

ECCO 2026_Preview_by_LucidQuest

ECCO 2026 Preview: Key Crohn’s and Colitis Highlights to Watch

February 19, 2026Our Insights,clinical trialsprecision medicine,AI in healthcare,real-world evidence,Ulcerative Colitis,Crohns Disease,Gastroenterology,inflammatory bowel disease,Conference Previews,Pharma CI,Insights,ECCO 2026

ECCO 2026 at a Glance Get ready for ECCO 2026. LucidQuest’s preview brings…

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Video Recap—February 19, 2026

February 19, 2026Blood cancers,Sanfilippo Syndrome Type A,BioPharma and Tech News,ExCellThera,autoimmune diseases,Zemcelpro,Eli Lilly,CareDx,Hunter Syndrome,AlloHeme,stem cell therapy,Kincell Bio,Ultragenyx,RegCell,Acute Myeloid Leukemia,MEDIPOST,Cell and Gene Therapy News,Myelodysplastic syndromes,knee osteoarthritis,Orna Therapeutics,REGENXBIOT-cell acute lymphoblastic leukemia,Gyala Therapeutics

This biweekly Cell and Gene Therapy video recap covers the latest regulatory…

by LucidQuest

Cell and Gene Therapy News

Cell and Gene Therapy Video Recap—February 19, 2026

February 19, 2026Gyala Therapeutics,Blood cancers,Our Insights,Sanfilippo Syndrome Type A,BioPharma and Tech News,ExCellThera,autoimmune diseases,Zemcelpro,Eli Lilly,CareDx,Hunter Syndrome,AlloHeme,stem cell therapy,Kincell Bio,Ultragenyx,RegCell,Acute Myeloid Leukemia,MEDIPOST,Cell and Gene Therapy News,Myelodysplastic syndromes,knee osteoarthritisOrna Therapeutics,REGENXBIO,T-cell acute lymphoblastic leukemia

This biweekly Cell and Gene Therapy video recap covers the latest regulatory…

by LucidQuest

Cardiovascular

Cardiovascular Today—Februrary 19, 2026

February 19, 2026BioPharma and Tech News,Stroke Preventioncardiac rehabilitation,pulmonary embolism,Cardiovascular News,aortic stenosis,ST-elevation myocardial infarction,Artificial intelligence in cardiology,Complex coronary disease,Percutaneous coronary intervention,Drug-coated balloons,TransMedics

This week's update in cardiovascular care covers key advancements in clinical…

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Today—February 19, 2026

February 19, 2026cystic fibrosis,gene therapy,Cell Therapy,BioPharma and Tech News,retinitis pigmentosa,Cell and Gene Therapy News,CAR T cell therapy,Large B-cell lymphoma,gene therapy manufacturingMesenchymal stem cell therapy,Blood cancers

This week's update in gene and cell therapy covers notable developments…

by LucidQuest

Rare Disease news

Rare Diseases Today—February 19, 2026

February 19, 2026Duchenne Muscular Dystrophy,BioPharma and Tech News,spinocerebellar ataxia,Orphan Drug Designation,Rare Disease News,Thymidine kinase 2 deficiency,Erythropoietic protoporphyria,FDA complete response letter,arginase-1 deficiencyNICE recommendation,rare disease drug approval

This is the weekly update in the rare disease field, summarizing the latest…

by LucidQuest

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Unnatural Products Novartis macrocyclic peptide licensing agreement

February 19, 2026clinical trials,market access,drug discovery,novartis,cardiovascular,biopharma,CMC,Lucid Diligence Brief,licensing deals,AI in drug discovery,macrocyclic peptidesprivate biotech

Lucid Diligence Brief: Unnatural Products Novartis macrocyclic peptide…

by Timos Papagatsias

Neuroscience

Neuroscience Video Recap—February 18, 2026

February 18, 2026Alto Neuroscience,Kite Pharma,Teva,Primary progressive multiple sclerosis,Amgen,Bocunebart,Alzheimer's Disease,Denovo Biopharma,roche,DB103,Yescarta,ALTO-101,BioPharma and Tech News,Biogen,Uplizna,Lundbeck,Eisai,LEQEMBI,Neuroscience NewsFenebrutinib,AJOVY

This biweekly Neuroscience video recap covers a range of key developments,…

by LucidQuest

Neuroscience

Neuroscience Today—February 18, 2026

February 18, 2026multiple sclerosis,Migraine Prevention,schizophrenia,BioPharma and Tech News,Chronic Pain,Neuroscience News,generalized myasthenia gravis,CNS drug developmentpsychosis,monoclonal antibody therapy

This weekly update in neuroscience highlights key regulatory actions, clinical…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.